StonvexLoading…
StonvexStonvexStonvexCore line items from KAVL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $484.66K | $6.89M | $13.09M | $12.76M |
Operating Income | $-16.65M | $29.80M | $23.80M | $4.50M |
Net Income | $-16.63M | $-6.70M | $-11.13M | $-14.37M |
EPS (Diluted) | $-1.51 | $-1.62 | $-4.13 | $-7.60 |
Total Assets | $669.26K | $16.00M | $19.39M | $12.44M |
Total Liabilities | $569.29K | $2.19M | $5.83M | $2.64M |
Cash & Equivalents | $0.00 | $0.00 | $0.00 | $3.69M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-2.98M | Not available |
Shares Outstanding | 11.59M | 8.52M | 2.79M | 2.67M |